![Marcella Ruddy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marcella Ruddy
Directeur/Membre du Conseil chez
UPSTREAM BIO, INC.
Fortune : 2 M $ au 31/08/2026
Profil
Marcella Kuhlman Ruddy is currently Director at MKRuddy Consulting LLC, Independent Director at Upstream Bio, Inc. since 2023, Independent Non-Executive Director at Sionna Therapeutics, Inc. starting in 2025, and Chief Medical Officer at both Tectonic Operating Co., Inc. and Tectonic Therapeutic, Inc. since 2021.
Former roles include Non-Executive Director at Polarean Imaging Plc from 2022 to 2024, Head-Early Clinical Development at Merck & Co., Inc. from 2004 to 2014, Vice President-Clinical Development at Alnylam Pharmaceuticals, Inc. from 2015 to 2016, Vice President-Clinical Immunology at EMD Serono, Inc. in 2014, Chief Medical Officer at AVROBIO, Inc., and Head-Group Inflammation at Regeneron Pharmaceuticals, Inc. from 2016 to 2021.
Education includes undergraduate studies at Princeton University and graduate and doctorate degrees from Washington University in St. Louis.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,35% | 03/09/2026 | 67 682 ( 0,35% ) | 2 M $ | 31/08/2026 |
UPSTREAM BIO, INC. -.--% | 09/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| 17/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Postes actifs de Marcella Ruddy
| Sociétés | Poste | Début |
|---|---|---|
| UPSTREAM BIO, INC. | Directeur/Membre du Conseil | 01/01/2023 |
| SIONNA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 08/01/2025 |
Tectonic Therapeutic, Inc.
 Tectonic Therapeutic, Inc. Miscellaneous Commercial ServicesCommercial Services Operates biotechnology company that transforming the discovery of novel G-protein-coupled receptors targeted therapies | Directeur Technique/Scientifique/R&D | 01/07/2021 |
MKRuddy Consulting LLC | Directeur/Membre du Conseil | - |
Anciens postes connus de Marcella Ruddy
| Sociétés | Poste | Fin |
|---|---|---|
| POLAREAN IMAGING PLC | Directeur/Membre du Conseil | 24/07/2024 |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/06/2021 |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/06/2016 |
EMD Serono, Inc.
 EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Corporate Officer/Principal | 01/11/2014 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/06/2014 |
Formation de Marcella Ruddy
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
86
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Regeneron Pharmaceuticals, Inc.
 Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Health Technology |
AVROBIO, Inc.
 AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose | Health Technology |
Polarean Imaging Plc
 Polarean Imaging Plc Medical SpecialtiesHealth Technology Designs, manufactures and sells noble gas polarizer devices & ancillary instruments | Health Technology |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for CF and rare diseases | Health Technology |
Tectonic Therapeutic, Inc.
Tectonic Therapeutic, Inc. Miscellaneous Commercial ServicesCommercial Services Operates biotechnology company that transforming the discovery of novel G-protein-coupled receptors targeted therapies | Commercial Services |
Upstream Bio, Inc.
 Upstream Bio, Inc. BiotechnologyHealth Technology Engages in developing treatments for inflammatory diseases | Health Technology |
MKRuddy Consulting LLC |
